CoChat

American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update

The DOI matches its Crossref record; 355 of the 356 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the standardized production of clinical practice guidelines (CPGs). Methods: Recommendations are based on diligent reviews of the clinical evidence with transparent incorporation of subjective factors, according to established AACE/ACE guidelines for guidelines protocols. Results: The Executive Summary of this 2020 updated guideline contains 52 recommendations: 21 Grade A (40%), 24 Grade B (46%), 7 Grade C (14%), and no Grade D (0%). These detailed, evidence-based recommendations allow for nuance-based clinical decision-making that addresses multiple aspects of real-world care of patients. The evidence base presented in the subsequent Appendix provides relevant supporting information for the Executive Summary recommendations. This update contains 368 citations: 123 (33.5%) evidence level (EL) 1 (highest), 132 (36%) EL 2 (intermediate), 20 (5.5%) EL 3 (weak), and 93 (25%) EL 4 (lowest). New or updated topics in this CPG include: clarification of the diagnosis of osteoporosis, stratification of the patient according to high-risk and very-high-risk features, a new dual-action therapy option, and transitions from therapeutic options. Conclusion: This guideline is a practical tool for endocrinologists, physicians in general, regulator…

Overview

Integrity signals

Registry

Crossref · 10.4158/gl-2020-0524suppl

Cites

355 of 356 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 356 references

Research works printed but not linked: 7

  1. Szulc, 2018, Use of CTX-I and PINP as bone turnover markers: Nationall Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability, Ann Biol Clin (Paris)., 76, 373
  2. 2008, J Rheumatol, 35, 488
  3. Wysowski, 2005, Alendronate and risedronate: reports of severe bone, joint, and muscle pain, Arch Intern Med., 165, 346
  4. Lewiecki, 2002, How common is loss of bone mineral density in elderly clinical practice patients receiving oral bisphosphonate therapy for osteoporosis, J Bone Miner Res., 17, S367
  5. Hochberg, 1999, Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group, Arthritis Rheum., 42, 1246, 10.1002/1529-0131(199906)42:6<1246::aid-anr22>3.0.co;2-u · DOI · Paper page
  6. Cummings, 2018, Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its extension, J Bone Miner Res., 33, 190, 10.1002/jbmr.3337 · DOI · Paper page
  7. Radonich, 2006, Community Environmental Monitoring Program 25th Anniversary Annual Workshop

Cited by

See all 1,182

Metadata

Authors
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., Pessah-Pollack, R., McClung, M., Wimalawansa, S. J., & Watts, N. B.
Affiliations
  • Loyola University Medical Center (US)
  • Houston Methodist (US)
  • University of Wisconsin–Madison (US)
  • Cincinnati VA Medical Center (US)
  • Harvard University (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • University of California, San Francisco (US)
  • Mayo Clinic (US)
  • University of Vermont Medical Center (US)
  • University of New Mexico Health Sciences Center (US)
  • Australian Catholic University (AU)
  • Emory University (US)
  • Mercy Health (US)
Corresponding author
Camacho, Pauline M.
Venue
Endocrine Practice
Publisher
Elsevier BV
Published
2020-05
Volume
26
Issue
Suppl 1
Pages
1-46
ISSN
1530-891X (ISSN-L)
OpenAlex
W4211141844
Cited by
1,182
References
356
Citations by year
2026: 195 · 2025: 228 · 2024: 248 · 2023: 193 · 2022: 182 · 2021: 110 · 2020: 20
FWCI
127.47
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Endocrine Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
postmenopausal osteoporosis, osteoporosis diagnosis, osteoporosis treatment, bone mineral density, fracture risk assessment, menopause
MeSH terms
Endocrinologists, Aged, Female, Humans, Middle Aged, United States, Absorptiometry, Photon, Bone Density, Osteoporosis, Postmenopausal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. https://app.cochat.ai/papers/10.4158/gl-2020-0524suppl
The paper
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., Pessah-Pollack, R., McClung, M., Wimalawansa, S. J., & Watts, N. B. (2020). American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocrine Practice. https://doi.org/10.4158/gl-2020-0524suppl

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.